Go to content
UR Home

Linezolid Concentrations in Plasma and Subcutaneous Tissue are Reduced in Obese Patients, Resulting in a Higher Risk of Underdosing in Critically Ill Patients: A Controlled Clinical Pharmacokinetic Study

URN to cite this document:
urn:nbn:de:bvb:355-epub-430633
DOI to cite this document:
10.5283/epub.43063
Simon, Philipp ; Busse, David ; Petroff, David ; Dorn, Christoph ; Ehmann, Lisa ; Hochstädt, Sophie ; Girrbach, Felix ; Dietrich, Arne ; Zeitlinger, Markus ; Kees, Frieder ; Kloft, Charlotte ; Wrigge, Hermann
[img]
Preview
PDF - Published Version
(1MB)
Date of publication of this fulltext: 15 Apr 2020 08:54


Abstract

Background: Linezolid is used for the treatment of soft tissue infections in critically ill patients. However, data for characterizing the pharmacokinetics (PK) and assessing whether effective concentrations are reached at the target site are lacking. We hypothesized that current dosing regimens do not lead to effective concentrations in the plasma and interstitial fluid (ISF) of subcutaneous ...

plus


Owner only: item control page
  1. Homepage UR

University Library

Publication Server

Contact:

Publishing: oa@ur.de

Dissertations: dissertationen@ur.de

Research data: daten@ur.de

Contact persons